

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 7.62601045 |
| 2 | cytidine metabolic process (GO:0046087) | 7.58548136 |
| 3 | cytidine catabolic process (GO:0006216) | 7.58548136 |
| 4 | cytidine deamination (GO:0009972) | 7.58548136 |
| 5 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 6.80075539 |
| 6 | cellular response to zinc ion (GO:0071294) | 6.46889934 |
| 7 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 6.27430121 |
| 8 | DNA deamination (GO:0045006) | 6.24988988 |
| 9 | ATP synthesis coupled proton transport (GO:0015986) | 5.66269692 |
| 10 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 5.66269692 |
| 11 | ribosomal small subunit assembly (GO:0000028) | 5.31720166 |
| 12 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 5.09907701 |
| 13 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 4.82819242 |
| 14 | respiratory electron transport chain (GO:0022904) | 4.72991149 |
| 15 | electron transport chain (GO:0022900) | 4.62995920 |
| 16 | cytolysis (GO:0019835) | 4.52112365 |
| 17 | sequestering of actin monomers (GO:0042989) | 4.36154469 |
| 18 | actin nucleation (GO:0045010) | 4.35688356 |
| 19 | positive regulation of calcium-mediated signaling (GO:0050850) | 4.34662949 |
| 20 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 4.20050079 |
| 21 | negative regulation of T cell apoptotic process (GO:0070233) | 4.08627483 |
| 22 | response to interferon-beta (GO:0035456) | 4.05867214 |
| 23 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 4.05811420 |
| 24 | protein complex biogenesis (GO:0070271) | 4.02126864 |
| 25 | negative regulation of viral genome replication (GO:0045071) | 3.85116367 |
| 26 | negative regulation of stress fiber assembly (GO:0051497) | 3.76011401 |
| 27 | viral transcription (GO:0019083) | 3.73105993 |
| 28 | negative T cell selection (GO:0043383) | 3.69448006 |
| 29 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 3.66481183 |
| 30 | hydrogen ion transmembrane transport (GO:1902600) | 3.64357203 |
| 31 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 3.61997658 |
| 32 | positive regulation of tolerance induction (GO:0002645) | 3.59345226 |
| 33 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 3.58704941 |
| 34 | translational termination (GO:0006415) | 3.56308133 |
| 35 | mitochondrial respiratory chain complex assembly (GO:0033108) | 3.54127200 |
| 36 | protein targeting to ER (GO:0045047) | 3.53699282 |
| 37 | protein neddylation (GO:0045116) | 3.50650655 |
| 38 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.49982028 |
| 39 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 3.47287173 |
| 40 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 3.44866779 |
| 41 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.44857118 |
| 42 | cotranslational protein targeting to membrane (GO:0006613) | 3.44771449 |
| 43 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 3.39735535 |
| 44 | purine deoxyribonucleotide catabolic process (GO:0009155) | 3.39282956 |
| 45 | protein localization to endoplasmic reticulum (GO:0070972) | 3.38370611 |
| 46 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.33786596 |
| 47 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 3.33656810 |
| 48 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 3.33629032 |
| 49 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 3.33629032 |
| 50 | cellular response to cadmium ion (GO:0071276) | 3.33424437 |
| 51 | regulation of natural killer cell mediated immunity (GO:0002715) | 3.30836963 |
| 52 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 3.30836963 |
| 53 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 3.29582704 |
| 54 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 3.29582704 |
| 55 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 3.29582704 |
| 56 | respiratory chain complex IV assembly (GO:0008535) | 3.28920734 |
| 57 | cytochrome complex assembly (GO:0017004) | 3.28747820 |
| 58 | positive regulation of defense response to virus by host (GO:0002230) | 3.28560339 |
| 59 | translational elongation (GO:0006414) | 3.26317640 |
| 60 | proton transport (GO:0015992) | 3.26004062 |
| 61 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 3.22730454 |
| 62 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 3.22730454 |
| 63 | pyrimidine nucleoside catabolic process (GO:0046135) | 3.21754969 |
| 64 | ribosomal small subunit biogenesis (GO:0042274) | 3.19541617 |
| 65 | positive regulation of fatty acid oxidation (GO:0046321) | 3.18789254 |
| 66 | hydrogen transport (GO:0006818) | 3.17974699 |
| 67 | macrophage chemotaxis (GO:0048246) | 3.16313913 |
| 68 | eosinophil chemotaxis (GO:0048245) | 3.15272573 |
| 69 | maturation of SSU-rRNA (GO:0030490) | 3.14648401 |
| 70 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.14415942 |
| 71 | negative regulation of ligase activity (GO:0051352) | 3.14405788 |
| 72 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 3.14405788 |
| 73 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 3.11652085 |
| 74 | negative regulation of lymphocyte apoptotic process (GO:0070229) | 3.10303464 |
| 75 | ATP biosynthetic process (GO:0006754) | 3.10196816 |
| 76 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 3.10000296 |
| 77 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 3.10000296 |
| 78 | positive regulation of cell killing (GO:0031343) | 3.09578218 |
| 79 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.08580810 |
| 80 | proteasome assembly (GO:0043248) | 3.07602797 |
| 81 | regulation of T cell tolerance induction (GO:0002664) | 3.06982889 |
| 82 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.06601448 |
| 83 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.06583337 |
| 84 | negative regulation of oxidoreductase activity (GO:0051354) | 3.06017539 |
| 85 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 3.03816729 |
| 86 | negative regulation by host of viral transcription (GO:0043922) | 2.99249349 |
| 87 | regulation of calcium-mediated signaling (GO:0050848) | 2.98304513 |
| 88 | positive regulation of smooth muscle cell migration (GO:0014911) | 2.92532593 |
| 89 | T cell migration (GO:0072678) | 2.92381298 |
| 90 | mannosylation (GO:0097502) | 2.92106993 |
| 91 | regulation of viral genome replication (GO:0045069) | 2.89624561 |
| 92 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 2.88197736 |
| 93 | negative regulation of nitric-oxide synthase activity (GO:0051001) | 2.87709436 |
| 94 | regulation of T cell receptor signaling pathway (GO:0050856) | 2.87528374 |
| 95 | eosinophil migration (GO:0072677) | 2.86696731 |
| 96 | antigen processing and presentation of peptide antigen via MHC class I (GO:0002474) | 2.86488675 |
| 97 | positive regulation of tyrosine phosphorylation of Stat5 protein (GO:0042523) | 2.83522632 |
| 98 | chaperone-mediated protein transport (GO:0072321) | 2.82823690 |
| 99 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 2.82150877 |
| 100 | purine deoxyribonucleotide metabolic process (GO:0009151) | 2.82035932 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.05130930 |
| 2 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.99606841 |
| 3 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 3.78705078 |
| 4 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 3.26175314 |
| 5 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 3.19375940 |
| 6 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 3.16738942 |
| 7 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.13871970 |
| 8 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.99420182 |
| 9 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.95796950 |
| 10 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.90042928 |
| 11 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.77578987 |
| 12 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.65169633 |
| 13 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.59459475 |
| 14 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.43268957 |
| 15 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.24418903 |
| 16 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.23940442 |
| 17 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.04575604 |
| 18 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.98100056 |
| 19 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 1.91206183 |
| 20 | MYB_26560356_Chip-Seq_TH2_Human | 1.85452943 |
| 21 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.83814528 |
| 22 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.83130295 |
| 23 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.80988730 |
| 24 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.72027363 |
| 25 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.70781138 |
| 26 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.69542413 |
| 27 | VDR_22108803_ChIP-Seq_LS180_Human | 1.69343942 |
| 28 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.68711821 |
| 29 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.68349810 |
| 30 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.67201849 |
| 31 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.62291051 |
| 32 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.52365004 |
| 33 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.51594694 |
| 34 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.51543874 |
| 35 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.48724360 |
| 36 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.48442993 |
| 37 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.46540645 |
| 38 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.45813410 |
| 39 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.43614360 |
| 40 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.42953393 |
| 41 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.41853961 |
| 42 | GATA3_26560356_Chip-Seq_TH2_Human | 1.41546981 |
| 43 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.36890508 |
| 44 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.34416059 |
| 45 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.34300968 |
| 46 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.31705079 |
| 47 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.31705079 |
| 48 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.31237752 |
| 49 | NANOG_20526341_ChIP-Seq_ESCs_Human | 1.29781110 |
| 50 | ERG_20517297_ChIP-Seq_VCAP_Human | 1.28510900 |
| 51 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.24584418 |
| 52 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.24182250 |
| 53 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.23576299 |
| 54 | AR_20517297_ChIP-Seq_VCAP_Human | 1.23521146 |
| 55 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.22951294 |
| 56 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.22705828 |
| 57 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.21648863 |
| 58 | MYB_26560356_Chip-Seq_TH1_Human | 1.21450150 |
| 59 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.19772227 |
| 60 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 1.19625309 |
| 61 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.19025427 |
| 62 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.15178077 |
| 63 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 1.15070761 |
| 64 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.13716473 |
| 65 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.13168893 |
| 66 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.11223169 |
| 67 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 1.10626019 |
| 68 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.09948292 |
| 69 | TAF2_19829295_ChIP-Seq_ESCs_Human | 1.08432531 |
| 70 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.08084357 |
| 71 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.06834875 |
| 72 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 1.05370095 |
| 73 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 1.03982672 |
| 74 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.03261027 |
| 75 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.02349584 |
| 76 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.02217978 |
| 77 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.00548781 |
| 78 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.00466875 |
| 79 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.00466875 |
| 80 | MYC_19829295_ChIP-Seq_ESCs_Human | 0.99601130 |
| 81 | UTX_26944678_Chip-Seq_JUKART_Human | 0.99516886 |
| 82 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.99275923 |
| 83 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 0.98846596 |
| 84 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.98177452 |
| 85 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 0.98026599 |
| 86 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 0.97632182 |
| 87 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 0.97369037 |
| 88 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 0.96218446 |
| 89 | PHF8_20622853_ChIP-Seq_HELA_Human | 0.95515552 |
| 90 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.94692622 |
| 91 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.94402929 |
| 92 | CTCF_20526341_ChIP-Seq_ESCs_Human | 0.94028496 |
| 93 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.93653691 |
| 94 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.92190347 |
| 95 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 0.92083021 |
| 96 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.91620073 |
| 97 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.90639632 |
| 98 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.90540161 |
| 99 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.88893482 |
| 100 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 0.88284308 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005671_abnormal_response_to | 4.69388576 |
| 2 | MP0008438_abnormal_cutaneous_collagen | 4.62088794 |
| 3 | MP0005503_abnormal_tendon_morphology | 4.24109556 |
| 4 | MP0003646_muscle_fatigue | 3.94948600 |
| 5 | MP0003279_aneurysm | 3.21793875 |
| 6 | MP0009785_altered_susceptibility_to | 3.10653125 |
| 7 | MP0003763_abnormal_thymus_physiology | 2.74400702 |
| 8 | MP0003011_delayed_dark_adaptation | 2.69217742 |
| 9 | MP0001835_abnormal_antigen_presentation | 2.38370363 |
| 10 | MP0002166_altered_tumor_susceptibility | 2.30086844 |
| 11 | MP0005275_abnormal_skin_tensile | 2.24191510 |
| 12 | MP0001958_emphysema | 2.09023542 |
| 13 | MP0005387_immune_system_phenotype | 2.02743912 |
| 14 | MP0001790_abnormal_immune_system | 2.02743912 |
| 15 | MP0009333_abnormal_splenocyte_physiolog | 2.00255134 |
| 16 | MP0005000_abnormal_immune_tolerance | 1.89635458 |
| 17 | MP0001661_extended_life_span | 1.82497800 |
| 18 | MP0005171_absent_coat_pigmentation | 1.74443344 |
| 19 | MP0002277_abnormal_respiratory_mucosa | 1.73256218 |
| 20 | MP0002933_joint_inflammation | 1.73139114 |
| 21 | MP0005025_abnormal_response_to | 1.71813625 |
| 22 | MP0002006_tumorigenesis | 1.71738218 |
| 23 | MP0002876_abnormal_thyroid_physiology | 1.71531249 |
| 24 | MP0002148_abnormal_hypersensitivity_rea | 1.71511239 |
| 25 | MP0010386_abnormal_urinary_bladder | 1.65064284 |
| 26 | MP0003195_calcinosis | 1.64796734 |
| 27 | MP0000685_abnormal_immune_system | 1.63599537 |
| 28 | MP0001800_abnormal_humoral_immune | 1.63026858 |
| 29 | MP0001542_abnormal_bone_strength | 1.62644582 |
| 30 | MP0003045_fibrosis | 1.59440806 |
| 31 | MP0002420_abnormal_adaptive_immunity | 1.54544308 |
| 32 | MP0002723_abnormal_immune_serum | 1.53677862 |
| 33 | MP0001243_abnormal_dermal_layer | 1.48966755 |
| 34 | MP0003786_premature_aging | 1.48945592 |
| 35 | MP0001819_abnormal_immune_cell | 1.45877311 |
| 36 | MP0003448_altered_tumor_morphology | 1.43912159 |
| 37 | MP0000569_abnormal_digit_pigmentation | 1.40708088 |
| 38 | MP0004145_abnormal_muscle_electrophysio | 1.37775975 |
| 39 | MP0002736_abnormal_nociception_after | 1.34109794 |
| 40 | MP0009379_abnormal_foot_pigmentation | 1.34057445 |
| 41 | MP0005360_urolithiasis | 1.33651313 |
| 42 | MP0005645_abnormal_hypothalamus_physiol | 1.32411506 |
| 43 | MP0006082_CNS_inflammation | 1.31787101 |
| 44 | MP0002405_respiratory_system_inflammati | 1.30294100 |
| 45 | MP0003866_abnormal_defecation | 1.29393861 |
| 46 | MP0002163_abnormal_gland_morphology | 1.27765358 |
| 47 | MP0002452_abnormal_antigen_presenting | 1.25701592 |
| 48 | MP0004130_abnormal_muscle_cell | 1.18134071 |
| 49 | MP0002108_abnormal_muscle_morphology | 1.15912025 |
| 50 | MP0002102_abnormal_ear_morphology | 1.15397507 |
| 51 | MP0000372_irregular_coat_pigmentation | 1.15216279 |
| 52 | MP0008995_early_reproductive_senescence | 1.12409996 |
| 53 | MP0001853_heart_inflammation | 1.10847469 |
| 54 | MP0005670_abnormal_white_adipose | 1.08476500 |
| 55 | MP0002282_abnormal_trachea_morphology | 1.07292524 |
| 56 | MP0000716_abnormal_immune_system | 1.05299509 |
| 57 | MP0005551_abnormal_eye_electrophysiolog | 1.03757472 |
| 58 | MP0001845_abnormal_inflammatory_respons | 1.03260749 |
| 59 | MP0002095_abnormal_skin_pigmentation | 0.98826444 |
| 60 | MP0009250_abnormal_appendicular_skeleto | 0.96141676 |
| 61 | MP0001968_abnormal_touch/_nociception | 0.93489964 |
| 62 | MP0004947_skin_inflammation | 0.92971053 |
| 63 | MP0004272_abnormal_basement_membrane | 0.92767297 |
| 64 | MP0002398_abnormal_bone_marrow | 0.92124251 |
| 65 | MP0009763_increased_sensitivity_to | 0.89570404 |
| 66 | MP0002060_abnormal_skin_morphology | 0.88960342 |
| 67 | MP0002168_other_aberrant_phenotype | 0.88925276 |
| 68 | MP0008875_abnormal_xenobiotic_pharmacok | 0.87899920 |
| 69 | MP0005174_abnormal_tail_pigmentation | 0.87620045 |
| 70 | MP0003186_abnormal_redox_activity | 0.85534411 |
| 71 | MP0010155_abnormal_intestine_physiology | 0.84703999 |
| 72 | MP0006072_abnormal_retinal_apoptosis | 0.84399993 |
| 73 | MP0001905_abnormal_dopamine_level | 0.84276079 |
| 74 | MP0008872_abnormal_physiological_respon | 0.83828975 |
| 75 | MP0008469_abnormal_protein_level | 0.83590672 |
| 76 | MP0002722_abnormal_immune_system | 0.82963127 |
| 77 | MP0009764_decreased_sensitivity_to | 0.82828037 |
| 78 | MP0004185_abnormal_adipocyte_glucose | 0.82490110 |
| 79 | MP0000751_myopathy | 0.81191746 |
| 80 | MP0005646_abnormal_pituitary_gland | 0.80359135 |
| 81 | MP0000689_abnormal_spleen_morphology | 0.79195063 |
| 82 | MP0006054_spinal_hemorrhage | 0.78756444 |
| 83 | MP0005389_reproductive_system_phenotype | 0.78616090 |
| 84 | MP0000703_abnormal_thymus_morphology | 0.78025298 |
| 85 | MP0004883_abnormal_blood_vessel | 0.75127678 |
| 86 | MP0002419_abnormal_innate_immunity | 0.75033610 |
| 87 | MP0005253_abnormal_eye_physiology | 0.74818677 |
| 88 | MP0002136_abnormal_kidney_physiology | 0.72318333 |
| 89 | MP0002295_abnormal_pulmonary_circulatio | 0.72276000 |
| 90 | MP0001119_abnormal_female_reproductive | 0.71951295 |
| 91 | MP0002429_abnormal_blood_cell | 0.71419098 |
| 92 | MP0005379_endocrine/exocrine_gland_phen | 0.71271574 |
| 93 | MP0004134_abnormal_chest_morphology | 0.70923911 |
| 94 | MP0010329_abnormal_lipoprotein_level | 0.69743983 |
| 95 | MP0002160_abnormal_reproductive_system | 0.67643253 |
| 96 | MP0004043_abnormal_pH_regulation | 0.67524146 |
| 97 | MP0001919_abnormal_reproductive_system | 0.66962913 |
| 98 | MP0005390_skeleton_phenotype | 0.66718661 |
| 99 | MP0005408_hypopigmentation | 0.66026836 |
| 100 | MP0002115_abnormal_skeleton_extremities | 0.65754356 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Aplastic anemia (HP:0001915) | 5.94374056 |
| 2 | Mitochondrial inheritance (HP:0001427) | 4.46902140 |
| 3 | T lymphocytopenia (HP:0005403) | 4.33023725 |
| 4 | Renal Fanconi syndrome (HP:0001994) | 4.30288560 |
| 5 | Increased hepatocellular lipid droplets (HP:0006565) | 4.28689258 |
| 6 | Hepatocellular necrosis (HP:0001404) | 4.27485986 |
| 7 | Abnormality of T cell number (HP:0011839) | 4.08653391 |
| 8 | Increased intramyocellular lipid droplets (HP:0012240) | 4.05501694 |
| 9 | Lipid accumulation in hepatocytes (HP:0006561) | 3.87050382 |
| 10 | Hepatic necrosis (HP:0002605) | 3.77483905 |
| 11 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.70544807 |
| 12 | Increased IgM level (HP:0003496) | 3.51586356 |
| 13 | Increased CSF lactate (HP:0002490) | 3.50748764 |
| 14 | Acute necrotizing encephalopathy (HP:0006965) | 3.45757989 |
| 15 | Increased muscle lipid content (HP:0009058) | 3.40262734 |
| 16 | Recurrent bronchitis (HP:0002837) | 3.38336280 |
| 17 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.37179660 |
| 18 | Exertional dyspnea (HP:0002875) | 3.35551599 |
| 19 | IgG deficiency (HP:0004315) | 3.34245369 |
| 20 | Autoimmune hemolytic anemia (HP:0001890) | 3.30216822 |
| 21 | Severe combined immunodeficiency (HP:0004430) | 3.25482281 |
| 22 | Small epiphyses (HP:0010585) | 3.19712866 |
| 23 | Sensory axonal neuropathy (HP:0003390) | 3.19650953 |
| 24 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 3.19183544 |
| 25 | Acute hepatic failure (HP:0006554) | 3.19182466 |
| 26 | Generalized aminoaciduria (HP:0002909) | 3.03318893 |
| 27 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 3.01437017 |
| 28 | Abnormality of renal resorption (HP:0011038) | 2.99746688 |
| 29 | Hypoproteinemia (HP:0003075) | 2.98402127 |
| 30 | Progressive macrocephaly (HP:0004481) | 2.97080946 |
| 31 | 3-Methylglutaconic aciduria (HP:0003535) | 2.94487916 |
| 32 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.88741252 |
| 33 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.88741252 |
| 34 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.82444727 |
| 35 | Thyroiditis (HP:0100646) | 2.80160451 |
| 36 | Abnormal number of erythroid precursors (HP:0012131) | 2.71184821 |
| 37 | Spontaneous abortion (HP:0005268) | 2.67361188 |
| 38 | Acute encephalopathy (HP:0006846) | 2.66879467 |
| 39 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.61098526 |
| 40 | Irregular epiphyses (HP:0010582) | 2.55411550 |
| 41 | Eosinophilia (HP:0001880) | 2.53962801 |
| 42 | Ulnar deviation of the wrist (HP:0003049) | 2.53513971 |
| 43 | Pancreatic cysts (HP:0001737) | 2.49848246 |
| 44 | Combined immunodeficiency (HP:0005387) | 2.49191333 |
| 45 | Abnormality of T cells (HP:0002843) | 2.47563498 |
| 46 | Abnormality of eosinophils (HP:0001879) | 2.46314898 |
| 47 | Pancytopenia (HP:0001876) | 2.39464749 |
| 48 | Increased serum lactate (HP:0002151) | 2.39322840 |
| 49 | Lactic acidosis (HP:0003128) | 2.38762509 |
| 50 | Partial duplication of the phalanx of hand (HP:0009999) | 2.34687654 |
| 51 | Congenital stationary night blindness (HP:0007642) | 2.30365553 |
| 52 | Absent thumb (HP:0009777) | 2.30122345 |
| 53 | Carpal bone hypoplasia (HP:0001498) | 2.29678375 |
| 54 | Chronic sinusitis (HP:0011109) | 2.29460642 |
| 55 | Glycosuria (HP:0003076) | 2.26768050 |
| 56 | Abnormality of urine glucose concentration (HP:0011016) | 2.26768050 |
| 57 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.25666090 |
| 58 | Hypergammaglobulinemia (HP:0010702) | 2.24949865 |
| 59 | Redundant skin (HP:0001582) | 2.23587380 |
| 60 | B lymphocytopenia (HP:0010976) | 2.21457098 |
| 61 | Attenuation of retinal blood vessels (HP:0007843) | 2.20870786 |
| 62 | Bronchitis (HP:0012387) | 2.19683889 |
| 63 | Reticulocytopenia (HP:0001896) | 2.17431259 |
| 64 | Irregular vertebral endplates (HP:0003301) | 2.15204032 |
| 65 | Molar tooth sign on MRI (HP:0002419) | 2.14039547 |
| 66 | Abnormality of midbrain morphology (HP:0002418) | 2.14039547 |
| 67 | Respiratory failure (HP:0002878) | 2.13713904 |
| 68 | Short tibia (HP:0005736) | 2.06845328 |
| 69 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 2.05632513 |
| 70 | Partial duplication of thumb phalanx (HP:0009944) | 2.03927512 |
| 71 | Cerebral edema (HP:0002181) | 2.03881152 |
| 72 | Fibular hypoplasia (HP:0003038) | 2.03342863 |
| 73 | Encephalitis (HP:0002383) | 1.95754065 |
| 74 | Granulocytopenia (HP:0001913) | 1.95560945 |
| 75 | Delayed epiphyseal ossification (HP:0002663) | 1.93199809 |
| 76 | Autoimmune thrombocytopenia (HP:0001973) | 1.93066686 |
| 77 | Parakeratosis (HP:0001036) | 1.91033259 |
| 78 | Abnormality of B cell number (HP:0010975) | 1.90527041 |
| 79 | Gastrointestinal infarctions (HP:0005244) | 1.90415106 |
| 80 | Abolished electroretinogram (ERG) (HP:0000550) | 1.89755216 |
| 81 | CNS demyelination (HP:0007305) | 1.89592410 |
| 82 | Abnormality of macrophages (HP:0004311) | 1.88305834 |
| 83 | Leukocytosis (HP:0001974) | 1.86635789 |
| 84 | Exercise intolerance (HP:0003546) | 1.85189863 |
| 85 | Amniotic constriction ring (HP:0009775) | 1.83919473 |
| 86 | Abnormality of placental membranes (HP:0011409) | 1.83919473 |
| 87 | Abnormal drinking behavior (HP:0030082) | 1.83814447 |
| 88 | Polydipsia (HP:0001959) | 1.83814447 |
| 89 | Aortic aneurysm (HP:0004942) | 1.82975117 |
| 90 | Optic disc pallor (HP:0000543) | 1.81265421 |
| 91 | Short hallux (HP:0010109) | 1.81245268 |
| 92 | Abnormality of the vertebral endplates (HP:0005106) | 1.80626418 |
| 93 | Pulmonary artery stenosis (HP:0004415) | 1.80306033 |
| 94 | Aplasia/Hypoplasia of the fibula (HP:0006492) | 1.79137422 |
| 95 | Decreased central vision (HP:0007663) | 1.78563252 |
| 96 | IgM deficiency (HP:0002850) | 1.76059247 |
| 97 | Chronic diarrhea (HP:0002028) | 1.75389516 |
| 98 | Neoplasm of head and neck (HP:0012288) | 1.74709664 |
| 99 | Esophageal neoplasm (HP:0100751) | 1.74709664 |
| 100 | Cellular immunodeficiency (HP:0005374) | 1.73592475 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | KDR | 6.21346050 |
| 2 | TESK2 | 5.80955901 |
| 3 | MAP3K12 | 3.50533157 |
| 4 | TESK1 | 3.43903245 |
| 5 | LIMK1 | 3.13541731 |
| 6 | TXK | 2.96101176 |
| 7 | MUSK | 2.72203675 |
| 8 | MAP4K1 | 2.68762542 |
| 9 | TLK1 | 2.67732205 |
| 10 | MYLK | 2.59746927 |
| 11 | ZAK | 1.98191052 |
| 12 | BUB1 | 1.93375450 |
| 13 | NME1 | 1.89976639 |
| 14 | TAOK3 | 1.81885757 |
| 15 | BCKDK | 1.68445504 |
| 16 | ITK | 1.65395644 |
| 17 | ADRBK2 | 1.63672151 |
| 18 | CAMKK2 | 1.53624127 |
| 19 | WNK4 | 1.53129336 |
| 20 | GRK1 | 1.45486872 |
| 21 | FRK | 1.36242515 |
| 22 | TEC | 1.35976865 |
| 23 | NLK | 1.31229624 |
| 24 | MAP3K11 | 1.28244187 |
| 25 | PIK3CA | 1.28240052 |
| 26 | TYK2 | 1.11495340 |
| 27 | VRK2 | 1.09522701 |
| 28 | CLK1 | 1.08389017 |
| 29 | ZAP70 | 1.07129530 |
| 30 | VRK1 | 1.04413546 |
| 31 | MAP4K2 | 1.03636996 |
| 32 | ADRBK1 | 0.97196883 |
| 33 | ROCK1 | 0.93908075 |
| 34 | PRKCQ | 0.91267228 |
| 35 | NUAK1 | 0.90853101 |
| 36 | MAPKAPK3 | 0.90500840 |
| 37 | GRK7 | 0.85392579 |
| 38 | SYK | 0.84445390 |
| 39 | JAK3 | 0.80665485 |
| 40 | LRRK2 | 0.80557060 |
| 41 | PAK3 | 0.80232486 |
| 42 | IKBKE | 0.78630267 |
| 43 | LCK | 0.76746594 |
| 44 | PDGFRB | 0.73149254 |
| 45 | KIT | 0.67921463 |
| 46 | FES | 0.67026696 |
| 47 | DDR2 | 0.66937700 |
| 48 | CAMKK1 | 0.65888299 |
| 49 | PAK1 | 0.65334118 |
| 50 | OXSR1 | 0.64703154 |
| 51 | BRSK2 | 0.63631335 |
| 52 | TRPM7 | 0.62659942 |
| 53 | TNK2 | 0.62338007 |
| 54 | ILK | 0.62129170 |
| 55 | CSK | 0.60341546 |
| 56 | DAPK1 | 0.59459896 |
| 57 | SCYL2 | 0.59360831 |
| 58 | STK16 | 0.58301807 |
| 59 | STK39 | 0.58227611 |
| 60 | INSRR | 0.57524939 |
| 61 | ABL2 | 0.56368029 |
| 62 | RPS6KA5 | 0.55433911 |
| 63 | MAPK15 | 0.54995750 |
| 64 | MAP3K5 | 0.54928036 |
| 65 | LYN | 0.52755638 |
| 66 | OBSCN | 0.52657391 |
| 67 | BTK | 0.51770888 |
| 68 | IGF1R | 0.51290637 |
| 69 | PIK3CG | 0.50560547 |
| 70 | INSR | 0.49218467 |
| 71 | ERBB3 | 0.48590683 |
| 72 | NME2 | 0.44230515 |
| 73 | DAPK3 | 0.43918330 |
| 74 | AURKA | 0.43157733 |
| 75 | CDK19 | 0.42950496 |
| 76 | PRKCH | 0.42362820 |
| 77 | TBK1 | 0.42344575 |
| 78 | CSF1R | 0.41269615 |
| 79 | GRK6 | 0.40129261 |
| 80 | PIM1 | 0.40129206 |
| 81 | PAK2 | 0.39562316 |
| 82 | PRKCA | 0.39524206 |
| 83 | PRKG2 | 0.37871015 |
| 84 | TIE1 | 0.37664471 |
| 85 | PKN1 | 0.37322585 |
| 86 | BMPR2 | 0.37209593 |
| 87 | IKBKB | 0.37129659 |
| 88 | PLK4 | 0.36134617 |
| 89 | CAMK1 | 0.34196924 |
| 90 | MARK3 | 0.34060235 |
| 91 | ABL1 | 0.32852257 |
| 92 | EIF2AK3 | 0.32318998 |
| 93 | CHEK2 | 0.31255081 |
| 94 | MAP2K6 | 0.29769116 |
| 95 | BRSK1 | 0.29358767 |
| 96 | PRKD1 | 0.29015699 |
| 97 | PINK1 | 0.28879391 |
| 98 | PASK | 0.28772702 |
| 99 | PRKACA | 0.26656803 |
| 100 | PRKCD | 0.26542677 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Proteasome_Homo sapiens_hsa03050 | 4.91401562 |
| 2 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 4.51936337 |
| 3 | Primary immunodeficiency_Homo sapiens_hsa05340 | 4.18410544 |
| 4 | Parkinsons disease_Homo sapiens_hsa05012 | 3.84997261 |
| 5 | Ribosome_Homo sapiens_hsa03010 | 3.65397358 |
| 6 | Alzheimers disease_Homo sapiens_hsa05010 | 2.84511565 |
| 7 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 2.60013142 |
| 8 | Huntingtons disease_Homo sapiens_hsa05016 | 2.40014448 |
| 9 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.19022547 |
| 10 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 2.15529509 |
| 11 | Protein export_Homo sapiens_hsa03060 | 2.11506789 |
| 12 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.96191245 |
| 13 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.95310812 |
| 14 | Mineral absorption_Homo sapiens_hsa04978 | 1.94267051 |
| 15 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.93866853 |
| 16 | RNA polymerase_Homo sapiens_hsa03020 | 1.89899848 |
| 17 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.77729913 |
| 18 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.72772933 |
| 19 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.62506655 |
| 20 | Allograft rejection_Homo sapiens_hsa05330 | 1.45269177 |
| 21 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.44995503 |
| 22 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.32091192 |
| 23 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.28787289 |
| 24 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.21190573 |
| 25 | Peroxisome_Homo sapiens_hsa04146 | 1.19337089 |
| 26 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.17825754 |
| 27 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.16647656 |
| 28 | ABC transporters_Homo sapiens_hsa02010 | 1.12910044 |
| 29 | Malaria_Homo sapiens_hsa05144 | 1.12829594 |
| 30 | Homologous recombination_Homo sapiens_hsa03440 | 1.04413249 |
| 31 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.03923205 |
| 32 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.03266599 |
| 33 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.03163325 |
| 34 | Measles_Homo sapiens_hsa05162 | 1.00600707 |
| 35 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.95028949 |
| 36 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.93459098 |
| 37 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.92882557 |
| 38 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.92591554 |
| 39 | Phototransduction_Homo sapiens_hsa04744 | 0.92355442 |
| 40 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.89323335 |
| 41 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.87932595 |
| 42 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.83542901 |
| 43 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.82491459 |
| 44 | DNA replication_Homo sapiens_hsa03030 | 0.78760564 |
| 45 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.78291517 |
| 46 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.76593476 |
| 47 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.72587175 |
| 48 | Shigellosis_Homo sapiens_hsa05131 | 0.69820451 |
| 49 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.69449144 |
| 50 | Retinol metabolism_Homo sapiens_hsa00830 | 0.67466751 |
| 51 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.64653771 |
| 52 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.64512566 |
| 53 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.63269181 |
| 54 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.63144874 |
| 55 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.62718898 |
| 56 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.62402343 |
| 57 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.62388947 |
| 58 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.62063952 |
| 59 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.58658896 |
| 60 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.58385809 |
| 61 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.56409882 |
| 62 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.56004599 |
| 63 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.55851746 |
| 64 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.55771113 |
| 65 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.55027738 |
| 66 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.54353055 |
| 67 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.53049487 |
| 68 | Viral myocarditis_Homo sapiens_hsa05416 | 0.52367286 |
| 69 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.50512592 |
| 70 | Olfactory transduction_Homo sapiens_hsa04740 | 0.49018975 |
| 71 | Salmonella infection_Homo sapiens_hsa05132 | 0.48774626 |
| 72 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.47337778 |
| 73 | Pertussis_Homo sapiens_hsa05133 | 0.47056357 |
| 74 | Metabolic pathways_Homo sapiens_hsa01100 | 0.46275158 |
| 75 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.46166102 |
| 76 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.44569010 |
| 77 | Purine metabolism_Homo sapiens_hsa00230 | 0.43565151 |
| 78 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.43331001 |
| 79 | Mismatch repair_Homo sapiens_hsa03430 | 0.40937125 |
| 80 | Taste transduction_Homo sapiens_hsa04742 | 0.40625005 |
| 81 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.39683433 |
| 82 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.39039168 |
| 83 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.37681127 |
| 84 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.35963139 |
| 85 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.35312275 |
| 86 | Basal transcription factors_Homo sapiens_hsa03022 | 0.34457676 |
| 87 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.33741370 |
| 88 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.32542477 |
| 89 | Sulfur relay system_Homo sapiens_hsa04122 | 0.30546586 |
| 90 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.30219596 |
| 91 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.29734807 |
| 92 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.27201275 |
| 93 | Histidine metabolism_Homo sapiens_hsa00340 | 0.26845638 |
| 94 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.26236993 |
| 95 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.25370589 |
| 96 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.24103982 |
| 97 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.23376636 |
| 98 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.23296222 |
| 99 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.20982154 |
| 100 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.20393006 |

